History of CML (Chronic Myeloid Leukemia)
"The discovery of the Philadelphia Chromosome took place in 1959 under a Fox Chase Cancer Center microscope and was the result of a collaboration between two scientists from both Fox Chase (then known as the Institute for Cancer Research) and the University of Pennsylvania.
This 40 years of research, starting from the discovery of an abnormal chromosome in CML cells and ending in the design of a drug that can negate the consequences of that chromosomal change, illustrate how slow yet steady progress in cancer research is having a positive impact on the outlook for people with cancer. As more is learned about DNA changes in other cancers, researchers expect progress in designing new drugs targeted at specific molecular changes of other cancer types.
The American Cancer Society in 1999,
40 years after the discovery of the Philadelphia Chromosome "
Extract of 50th Anniversary of the Discovery of the Philadelphia Chromosome by Fox Chase Cancer Center
The survivors: How an experimental treatment saved patients and changed medicine
APRIL 25, 2017, Stat News
Clinical trial saves leukemia patient from death (History of STI-571 1999 ) Video
April 14, 2016, Virginia Garner
Leukemia Patient Tells of New Drug (History of STI-571 1999 ) Video
April 12, 2016, Virginia Garner
A Critical History of Chronic Myeloid Leukemia
January 2, 2014, Mediterranean Journal of Hematology and Infectious Diseases
2012 (28th) Japan Prize: Dr. Rowley / Dr. Druker / Dr. Lydon Video
April 24, 2012, JapanPrize
50th Anniversary of the Discovery of the Philadelphia Chromosome
September 28, 2010, Fox Chase Cancer Center
The End of Cancer is within reach Video
2009, Knight Cancer institute, OHSU
Executive Summary of a Book: Magic Cancer Bullet
May 23, 2009, Discovery Medecine
OHSU Scientists Begin Human Trials Of A Drug Aimed At The Underlying Cause Of Chronic Myelogenous Leukemia by EurekAlert
‘’The first patient, 68-year-old Bud Romine from Tillamook, Ore., will take his first dose of the experimental drug (on Thursday, June 25, 1998, at Oregon Health Sciences University’’
The first day of clinical trials for Gleevec, Bud and Yvonne by DNA Learning Center Video
Translation of the Philadelphia chromosome into therapy for CML
December 15, 2008, Journal Blood
The history of myeloproliferative disorders: before and after Dameshek
2008, Mendeley
The Story of Gleevec
By Innovation.org
The History Of Glivec
December 27, 2005, Medical News Today
THE BCR-ABL STORY: Bench to Bedside and Back
2004, Research Computing at Dana-Farber Cancer Institute
A History of Leukemia by Dr. John M. Goldman
January 2003, Medscape
Powerful Anti-Cancer Drug Emerges from Basic Biology
May 2001, New-York Times
The Miracle Worker
February 2001, by Nick Charles
Suzan Mc Namara is the patient who started a petition to Novartis which is a corporation that produced pills for clinical trials conducted by Dr. Druker for CML patients
APRIL 25, 2017, Stat News
Clinical trial saves leukemia patient from death (History of STI-571 1999 ) Video
April 14, 2016, Virginia Garner
Leukemia Patient Tells of New Drug (History of STI-571 1999 ) Video
April 12, 2016, Virginia Garner
A Critical History of Chronic Myeloid Leukemia
January 2, 2014, Mediterranean Journal of Hematology and Infectious Diseases
2012 (28th) Japan Prize: Dr. Rowley / Dr. Druker / Dr. Lydon Video
April 24, 2012, JapanPrize
50th Anniversary of the Discovery of the Philadelphia Chromosome
September 28, 2010, Fox Chase Cancer Center
The End of Cancer is within reach Video
2009, Knight Cancer institute, OHSU
Executive Summary of a Book: Magic Cancer Bullet
May 23, 2009, Discovery Medecine
OHSU Scientists Begin Human Trials Of A Drug Aimed At The Underlying Cause Of Chronic Myelogenous Leukemia by EurekAlert
‘’The first patient, 68-year-old Bud Romine from Tillamook, Ore., will take his first dose of the experimental drug (on Thursday, June 25, 1998, at Oregon Health Sciences University’’
The first day of clinical trials for Gleevec, Bud and Yvonne by DNA Learning Center Video
Translation of the Philadelphia chromosome into therapy for CML
December 15, 2008, Journal Blood
The history of myeloproliferative disorders: before and after Dameshek
2008, Mendeley
The Story of Gleevec
By Innovation.org
The History Of Glivec
December 27, 2005, Medical News Today
THE BCR-ABL STORY: Bench to Bedside and Back
2004, Research Computing at Dana-Farber Cancer Institute
A History of Leukemia by Dr. John M. Goldman
January 2003, Medscape
Powerful Anti-Cancer Drug Emerges from Basic Biology
May 2001, New-York Times
The Miracle Worker
February 2001, by Nick Charles
Suzan Mc Namara is the patient who started a petition to Novartis which is a corporation that produced pills for clinical trials conducted by Dr. Druker for CML patients
